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Loss of H3K36 Methyltransferase
SETD2 Impairs V(D)J Recombination
during Lymphoid Development
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Vipul Kumar,6,7 Yijun Xiong,1 Elsa Callen,8 Putzer J. Hung,3,9 Zhaohui Feng,1 Richard P. Koche,10 X. Shirley Liu,5
Jayanta Chaudhuri,11,12 Andre Nussenzweig,8 Barry P. Sleckman,3 and Scott A. Armstrong1,13,*
SUMMARY
Repair of DNA double-stranded breaks (DSBs) during lymphocyte development is essential for V(D)J
recombination and forms the basis of immunoglobulin variable region diversity. Understanding of this
process in lymphogenesis has historically been centered on the study of RAG1/2 recombinases and a
set of classical non-homologous end-joining factors.Much less has been reported regarding the role of
chromatin modifications on this process. Here, we show a role for the non-redundant histone H3 lysine
methyltransferase, Setd2, and its modification of lysine-36 trimethylation (H3K36me3), in the pro-
cessing and joining of DNA ends during V(D)J recombination. Loss leads to mis-repair of Rag-induced
DNA DSBs, especially when combined with loss of Atm kinase activity. Furthermore, loss reduces
immune repertoire and a severe block in lymphogenesis as well as causes post-mitotic neuronal
apoptosis. Together, these studies are suggestive of an important role of Setd2/H3K36me3 in these
two mammalian developmental processes that are influenced by double-stranded break repair.
INTRODUCTION
In early normal lymphocyte development, gene segments that will eventually encode the immunoglob-
ulin (Ig) and T cell receptor (TCR) variable regions are recombined from Variable (V), Diversity (D), and
Joining (J) gene segments in a process known as V(D)J recombination (Alt et al., 2013). During the
DNA recognition and cleavage stage, recombination signal sequences (RSSs) that flank the individual
V, D, and J gene segments are targets of RAG1/2 endonucleases and result in the generation of hair-
pinned coding ends (CEs) and blunt-ended signal ends (SEs) (Alt et al., 2013; Schatz and Swanson,
2001). In the second phase of V(D)J recombination, and-processing and end-ligation of CEs and SEs
are mediated by classical non-homologous end-joining (C-NHEJ) factors and produce an imprecisely re-
paired coding joint (CJ) consisting of V(D)J exons and a precisely repaired but discarded circular signal
joint (SJ) (Alt et al., 2013; Schatz and Swanson, 2001). A set of core C-NHEJ factors (KU70, KU80, XRCC4,
and LIG4) is absolutely essential for end-joining and is evolutionarily conserved (Alt et al., 2013; Kumar et
al., 2014). Loss or defects of C-NHEJ factors can impair end-processing (DNA-PKCs, ARTEMIS) or end-
joining (KU proteins, XRCC4, XLF, LIG4) and results in severe immunodeficiencies in both mouse models
and human disease (Alt et al., 2013; Kumar et al., 2014; Bassing et al., 2002). The DNA damage protein,
ataxia telangiectasia mutated (ATM); its target, histone H2AX; and DNA damage response adaptor pro-
tein, MRI, are all also involved in the end-ligation process (Bredemeyer et al., 2006; Yin et al., 2009; Hung
et al., 2018). The single loss of any of these factors, or C-NHEJ factor XLF, has only modest effects on
lymphogenesis and V(D)J recombination (Bredemeyer et al., 2006; Yin et al., 2009; Hung et al., 2018;
Li et al., 2008). In addition to loss of the core C-NHEJ factors, combined deficiencies of proteins non-
essential for the end-joining reaction can severely impair C-NHEJ to a similar extent, as in the case of
combined loss of Xlf and Atm or Xlf and Mri (Kumar et al., 2016; Hung et al., 2018; Li et al., 2008; Lescale
et al., 2016; Zha et al., 2011).
Another mammalian developmental process that utilizes C-NHEJ for repair of double-strand breaks (DSBs)
is embryonic neurogenesis (Frappart and McKinnon, 2008). Neural progenitors that have exited the cell cy-
cle and are migrating out of the embryonic ventricular zones as they differentiate are thought to rely on
NHEJ-mediated repair of DSBs (Frappart and McKinnon, 2008). In mice, loss of core C-NHEJ factors leads
to apoptosis of post-mitotic neurons and embryonic lethality (Gao et al., 1998; Frank et al., 2000; Gu et al.,
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2000). Moreover, the same synthetic lethal combinations that result in severe lymphocyte developmental
blocks (e.g., MRI and XLF) also display similar post-mitotic neuronal apoptosis (Hung et al., 2018; Abra-
mowski et al., 2018), indicating the critical role of end-ligation and C-NHEJ in the repair of DSBs during
neurogenesis.
Histone H3 lysine-36 tri-methylation (H3K36me3) is a histone modification that is catalyzed by the non-
redundant histone methyltransferase, SETD2 (Wagner and Carpenter, 2012). H3K36me3 is associated
with actively transcribed genes, and SETD2 plays important roles in the control of gene expression (Wagner
and Carpenter, 2012). Loss-of-function mutations in SETD2 or dominant negative ‘‘onco-histone’’ muta-
tions in the H3K36 residue itself have been described in a broad array of malignancies, particularly in
hematopoietic and central nervous system (CNS) tumors (Parker et al., 2016; Zhang et al., 2012; McKinney
et al., 2017; Moffitt et al., 2017; Zhu et al., 2014; Lu et al., 2016). In mammalian cells, SETD2 regulates specific
steps of the DNAdamage response duringmismatch repair (MMR) and homologous recombination (HR) (Li
et al., 2013; Pfister et al., 2014; Aymard et al., 2014). More recently, a role for Setd2 in normal thymocyte
development and V(D)J recombination was described (Ji et al., 2019). Although a role for H3K36 methyl-
ation in NHEJ had been previously suggested in yeast (Fnu et al., 2011), insights into the mechanism for
how this post-translation histone modification in mammalian cells may impact this mode of repair remains
unknown. Thus, to determine the role, if any, of Setd2 and H3K36me3 in this mode of DNA repair in mam-
mals, we studied its loss in two developmental pathways that utilize NHEJ. Here, we specifically show that
whereas loss of Setd2/H3K36me3 does not completely abrogate repair of DSBs, loss leads to mis-repair in
B-cell lymphoid development of Rag-induced DNA DSBs, especially when combined with loss of ATM
kinase activity. Loss of Setd2 leads to the increased formation of aberrant hybrid joints and additionally
leads to reductions in overall B cell repertoire. Finally, loss of Setd2 also leads to post-mitotic neuronal
apoptosis.
RESULTS
Loss of Setd2 Disrupts Normal Hematopoiesis, Particularly Lymphopoiesis
The complete loss of Setd2 is embryonic lethal at embryonic day 10.5 (E10.5)–E11.5 (Hu et al., 2010).
Therefore, to study the role of Setd2 in normal and malignant hematopoiesis, we previously generated a
conditional mouse model expressing Cre-recombinase under inducible (Mx1) or constitutive (Vav1)
hematopoietic lineage-restricted promoters (Mar et al., 2017). The loss of Setd2 ablated H3K36me3 in he-
matopoietic tissues through excision of exon 3 of Setd2 (Figure 1A). Heterozygous mice had no overt
hematopoietic phenotype (Figures S1A, S1B and S2D), whereas homozygous loss of Setd2 resulted in a sig-
nificant perturbation of normal hematopoiesis, including decreased overall bone marrow cellularity (Fig-
ure 1B), significant loss of mature lymphoid cells (B220+ B cells and CD3+ T cells) in the bone marrow,
and expansion of erythroid (Ter119+) cells (Figures 1C and 1D). The significant reduction in T cells in the
bone marrow observed upon complete Setd2 loss was also mirrored by a severe diminution of thymic
size (Figure 1E), which was concomitant with significant splenomegaly (Figure 1F). Strikingly, the spleno-
megaly was due to the aberrant expansion of erythroid cells and significant ablation of B-lymphoid
(B220+) populations (Figure 1G). In addition, loss of Setd2 induced qualitative and quantitative defects in
hematopoietic stem cells, as well as abnormal erythroid progenitor expansion in the bone marrow (Figures
1D, 1G, 1H, S1C–S1F, and S2A–S2C). These hematopoietic phenotypes are consistent with other reports on
Setd2 knockoutmice (Zhou et al., 2018; Zhanget al., 2018; Ji et al., 2019). Altogether, thesedata indicate that
loss of Setd2 disrupts normal hematopoiesis and severely impacts lymphoid development.
Setd2/H3K36me3 Is Important in Normal Lymphocyte Development
We and others (Zhou et al., 2018; Zhang et al., 2018; Ji et al., 2019) observed that loss of Setd2 early in
hematopoiesis resulted in significant depletions of the lymphoid populations in the bone marrow, spleen,
and thymus (Figures 1C, 1D, 1G and S1). To rule out that these early developmental deficiencies were not
solely the result of reduced numbers of early lymphoid progenitors (Figure S1C), we crossed our knockout
mice with multiple B lymphoid lineage-restricted Cre-recombinase-expressing lines and found that
whereas an early and profound proB block in development was only observed upon early deletion of
Setd2 (Mx1, Vav1cre) (Figure 2A), the deletion of Setd2 in later stages of B cell development (with hCD2,
Mb1, and Cd19cre) resulted in abnormal lymphocytic output that was more apparent in more mature B
cell populations (Figures 2B and 2C). Specifically, loss of Setd2 induced at later stages of B cell develop-
ment significantly reduced detectable mature B cells (IgM+IgD+) in the bone marrow (Figures 2B and
2C) and resulted in the significant depletion of B cell lineage cells in the spleen (Figure 2C). These data
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suggest that Setd2/H3K36me3 is important in B lymphopoiesis at different stages, but that the severe block
at the proB cell stage was only apparent with early loss in hematopoiesis.
Setd2/H3K36me3 Is Crucial for Normal Immunoglobulin Rearrangement in Early Lymphocyte
Development Recombination
The severe block in early B cell development was striking and warranted further examination. Early loss of Setd2/
H3K36me3 blocked B cell development at the proB cell stage with similar total numbers of Fraction A (FrA)-








Figure 1. Loss of Setd2/H3K36me3 Disrupts Normal Hematopoiesis and Severely Arrests Lymphoid
Development
(A) Western blot for H3K36me3, total H3, and Gapdh in bone marrow (BM), spleen (spl), and thymus (thy) ofMx1/Vav1cre
Setd2D/D and Setd2f/f littermate controls.
(B) Total cell count of whole bone marrow (n = 6 for all groups).
(C) Ratio of Mx1 and Vav1 Setd2D/D to controls of total cellularity of whole bone marrow (WBM), lineage-negative bone
marrow cells (LIN), B220+ B cells in bone marrow, and thymocytes (n = 15 for all groups).
(D) Percent composition of differentiated hematopoietic cell populations in WBM, B cell (B220+), T cell (Cd3+), myeloid
(Mac1+/Gr1+), and erythroid (Ter119+) (n=6 for all groups).
(E) Thymic (n = 10) and (F) spleen (n = 100) weights for Setd2D/D and Setd2f/f littermate controls.
(G) Percent composition of differentiated hematopoietic cell populations in spleen.
(H) Total cellularity of LSK (LinSca1+Kit+) and SLAM (LSK Cd150+Cd48-) hematopoietic stem populations (n = 6 for all
groups).
**, p < 0.01 ***, p < 0.001. See also Figures S1 and S2.
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proB cell stagewas concomitantwith a near-complete ablation of immature IgM+B cells in the bonemarrow and
spleen (Figures 3AandS3B). Similarly,Setd2D/Dmiceexhibitedablock inearly T celldevelopmentat thedouble-
negative stage (DN:CD4CD8-), with an accumulation at the DN3 stage (Figure 3B). This arrest at the DN3 stage
was similarly observed inMx1-cre-driven exon 6-7 deletion Setd2 knockoutmouse (Ji, et al., 2019). Thus, lympho-
poiesis in Setd2D/Dmice appeared to be arrested at stages wherein V(D)J recombination occurs and is reminis-
cent of the lymphopenia observed with deficiency of factors necessary for V(D)J recombination (Alt et al., 2013;
Kumar et al., 2014; Bassing et al., 2002). In all early B/T cell progenitor populations of Setd2D/Dmice, develop-




Figure 2. Setd2/H3K36me3 Important for B Cell Development at Different Stages
(A) Schematic of ontological expression of various B-lineage-restricted cre-recombinase mouse lines crossed to Setd2f/f
mice with Igh locus rearrangement status indicated, and representative flow cytometry of B220+ early B cells progenitors
(proB and preB cells) of control, Vav/Mx1, hCD2, Cd19, and Mb1cre Setd2D/D mice.
(B) (i) Representative flow cytometry of bone marrow stained for early B cell progenitors and mature and immature B cell
markers (IgM and IgD). (ii) Total bone marrow cellularity. (iii) Fraction composition of B220+, proB (B220+Cd43+IgM),
preB (B220+Cd43+IgM), immature B (B220+Cd43+IgM+), and mature B cell (B220+IgM+IgD+) populations of hCD2
(n = 7), Mb1 (n = 14), Cd19 (n = 9) Setd2D/D, and sex- and age-matched littermate controls.
(C) Spleen (i) weight (n = 14 for all groups), (ii) total cellularity (n = 3 for all groups), and (iii) percentage composition of
different B cell populations in bone marrow and spleen (n = 6 for all groups).
Significance indicated as comparison with controls. *p < 0.05, **p < 0.01, ***p < 0.001, error bars represent SD.
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despite similar in vivo proliferation rates and cell cycle status (Figures 3D and S3H). Furthermore, Setd2D/D proB
cells did not display any significant differences in the expression of factors related to V(D)J recombination at the
gene or protein level (Figures S4A–S4C). The arrest in B cell, but not in T cell, development in Setd2D/D mice





Figure 3. Loss of Setd2/H3K36me3 Severely Arrests Lymphoid Development
(A) Representative flow cytometry analysis of early B cell progenitors in B220+ bone marrow and total cellularity of B cell
progenitor proportions of Vav/Mx1cre Setd2D/D and controls (n = 9).
(B) Representative flow cytometric analysis of thymic cells, and total cellularity of thymic progenitor populations
in Setd2D/D and Setd2f/f controls. DN: Cd4-Cd8-, DN1: DN Cd44+Cd25-; DN2: DN Cd44+Cd25+; DN3: DN Cd44-Cd25+
(n = 8).
(C) Annexin V+ of B (n = 9) and T cell (n = 5) progenitor populations.
(D) In vivo bromodeoxyuridine (BrdU) incorporation in early B and T cell progenitor compartments (n = 3). All values for
BrdU were non-significant.
(E) Representative immature B cell (B220+sIgM+) flow cytometric analysis and total cellularity of immature surface IgM+
population of bone marrow cells isolated from both legs and hips of Setd2 mice crossed to mice transgenic for the Ig
heavy chain complex (IgHelMD4) specific for hen egg lysozyme (HEL) (n = 4 for Setd2f/f, n = 5 for Setd2D/DMD4, and n = 3
for Setd2D/D).
*** p<0.001, error bars represent SD. See also Figures S3 and S4.





Figure 4. Loss of Setd2/H3K36me3 Does Not Alter Chromatin Architecture or Accessibility of the Early proB Igh
Locus and Causes Abnormal V(D)J Recombination
(A) H3K36me3 ChIP sequencing of the Igh locus of Cd19/+ proB (B220+Cd43+IgM) cells from bone marrow of Vav
Setd2D/D and controls. (n = 3 for all groups). Magnification of region of Igh with focal H3K36me3; loss of representative
H3K36me3 tracks overlaid with assay for transposase-accessible chromatin (ATAC)-seq of same region from control proB
cells for reference. Annotation of critical regulatory sites as indicated.
(B) Representative ATAC-seq tracks of regulatory region of the Igh locus described in (A) of sorted Cd19- proB cells from
two matched control and Setd2 knockout sorted proB cells.
(C) Representative ChIP-PCR of regulatory region for histone H3 marks K36me3, K9ac, and K4me3. Data representative of
n = 3 independent experiments.
(D) Representative ChIP-PCR of Rag1 and Hmgb2 of proB cells from Setd2D/D and controls at the same regulatory region
with standard deviations as indicated, n = 3 independent experiments.
(E) Relative quantitation of sterile transcription of DH genes, Cm, and enhancer RNAs of proB cells from Setd2D/D and
controls. Data represented as an average of three independent ChIP-PCRs from three independently sorted proB cell
populations.
6 iScience 23, 100941, March 27, 2020
and productive immunoglobulin heavy chain (Igh) locus (Figure 3E), indicating a role for Setd2/H3K36me3 in en-
forcing normal V(D)J recombination.
Loss of Setd2/H3K36me3 Does Not Abrogate Chromatin Architecture or Accessibility of the
Early proB Igh Locus and Causes Aberrant V(D)J Recombination
To determine the impact of loss of Setd2/H3K36me3 on the Igh locus at the proB stage, we conducted
chromatin immunoprecipitation (ChIP) sequencing and found both a global loss of H3K36me3 across
the genome and a focal loss on the Igh locus where a well-studied critical regulatory region near the Em
enhancer resides (Chowdhury and Sen, 2001) (Figures 4A and S5A). As accessibility of this region is critical
for B cell development (Chowdhury and Sen, 2001; Chakraborty et al., 2009), we wanted to ascertain if the
loss of H3K36me3 affected local chromatin architecture or accessibility. In proB cells, ablation of H3K36me3
neither affected chromatin accessibility (Figures 4B and S5B) nor disrupted the local levels of H3K4me3 and
H3K9ac (Figure 4C), two histone modifications essential for maintaining an open and actively transcribed
chromatin structure at this regulatory region (Chowdhury and Sen, 2001; Chakraborty et al., 2009) and for
H3K4me3, the recruitment and activation of the Rag2 protein itself (Shimazaki and Lieber, 2014; Johnson
et al., 2010; Ji et al., 2010; Matheson and Corcoran, 2012; Bettridge et al., 2017). Loss of H3K36me3 did
not significantly affect the methylation states of mono-, di-, or tri-methyl lysine-27 or mono- and di-methyl
lysine-36 residues in this region (Figure S5C). We detected equivalent recruitment of Rag1 and Hmgb2 to
this same region on the Igh locus (Shimazaki and Lieber, 2014; Johnson et al., 2010; Ji et al., 2010; Matheson
and Corcoran, 2012) (Figure 4D), suggesting that the initiation phase of the V(D)J recombination reaction
was intact. We were also not able to detect in sorted FrA proB cells any evidence of Rag1 recruitment or
H3K36me3 at variable gene families on the Igh locus in either Setd2-deficient cells or controls (Figure S5D).
In addition, the level of sterile transcription of Igh genes was only mildly reduced (Figure 4E), particularly
when compared with deletion of the Em enhancer, which causes significant transcriptional dysregulation
(Chakraborty et al., 2009). Upon closer examination of recovered V(D)J recombination products from
proB cells, we observed that Setd2 deficiency resulted in aberrant recombination and, in some cases,
lack of expected rearrangement products altogether (Figures 4F and S5E). Combined, these data are
suggestive that the V(D)J recombination defect is not due to decreased expression or regulation of the
Igh locus, but due to defects in the repair phase of the reaction.
Aberrant End-Joining of Rag-Induced DSB with Setd2/H3K36me3 Deficiency
To ascertain if defects in Setd2-deficient lymphogenesis could be a consequence of impaired Rag-inducedDSB
repair during V(D)J recombination, we generated murine Setd2-deficient (Setd2/), Ku80/ (Xrcc5/), and
Lig4 / late-proB v-Abelson (v-Abl)-transformed lines expressing a Bcl2 transgene by CRISPR/Cas9-mediated
inactivation (Figures S6A–S6D) (Hung et al., 2018; Jacobsen et al., 2006). Loss of Setd2 in v-Abl cells neither per-
turbed the expression of factors involved in V(D)J recombination nor affected the cell cycle distribution of these
cells (Figures S7A–S7C) in vitro. Treatment with Abl kinase inhibitor imatinib (STI) induces G1 cell-cycle arrest
and Rag1/2 expression leading to k light chain rearrangement (Hung et al., 2018; Jacobsen et al., 2006) (Fig-
ure S8A). We additionally introduced a chromosomally integrated inversion recombination substrate (pMG-
INV), which can be used to assess the efficiency of V(D)J recombination by measuring GFP expression in cells
and/or visualization of the repair products and intermediates by Southern blotting and PCR-based strategies
(Hung et al., 2018) (Figure 5A). Inactivation of ATM kinase activity with an inhibitor (ATMi) is sufficient to induce
the formation of hybrid joints (HJs, joining of CEs to SEs) (Bredemeyer et al., 2006) and could additionally be
used to observe aberrant V(D)J recombination.
Comparable rearrangement efficiency of the pMG-INV substrate was observed in both wild-type (WT) and
Setd2/ v-Abl cells treated with imatinib, as indicated by GFP expression (Figure 5B). As expected, treat-
ment of WT v-Abl cells with ATMi resulted in a modest (25%) decrement in GFP expression (Figure 5B).
Strikingly, treatment of Setd2/ cell lines with ATMi resulted in a 60% reduction in GFP expression (Fig-
ure 5C). This finding is reminiscent of the severe defect in GFP expression found in Xlf-deficient v-Abl cells
Figure 4. Continued
(F) Schematic and representative results of PCR assay to detect V(D)J recombination products of rearrangement of the Igh
locus of different VH families of sorted proB cells from Setd2D/D (KO) and controls (WT). Empty and filled triangles
represent primers. No product meant germline non-rearrangement. Image representative of n = 3 independent PCR
experiments.
Error bars represent SD. See also Figure S5.







Figure 5. Aberrant End-Joining of Rag-Induced DSB with Setd2/H3K36me3 Deficiency
(A) Schematic of recombination substrate pMG-INV. Unrearranged (UR) and SE and CE intermediates and resulting SJs
and CJs. Long-terminal repeats (LTRs), XbaI and NheI restriction digestion sites, recombination signal sequences (RSSs),
GFP, Thy1.2 cDNA, and corresponding probes shown.
(B) Representative flow cytometric analysis of GFP expression in control and Setd2/ pMG-INV v-Abl cells treated with
Abl kinase inhibitor imatinib (STI-571) and ATM kinase inhibitor (ATMi, KU55933) for 48 and 96 h.
(C) GFP expression of pMG-INV harboring v-Abl cell lines treated for 72 h with imatinib G ATMi assessed by flow
cytometry. Control, Lig4/, and at least four independently derived Xrcc5/ and Setd2/ v-Abl clones were treated in
n = 4 independent induction experiments. Significance to controls to STI-571 treatment alone condition was calculated.
***p < 0.001, error bars represent SD.
(D) Southern blot analysis of genomic DNA from induced Setd2/ and control lines that were digested with (i and ii) XbaI
and (iii) NheI hybridized with (i and iii) Thy1 or (ii) GFP probe. Hybrid Joins (HJ) indicated as well (joint of CEs and SEs).
(E) Schematic of PCR method to detect the formation of a coding joint and hybrid joint recombination product of the
pMG-INV retroviral recombination substrate, and PCR result of pMG-INV coding and hybrid joints from indicated v-Abl
cell clones treated for 72 h with ABLki with or without ATMki (KU55933). Il-2 gene PCR was used as a loading control. Blue
arrow indicates coding joint product, and red arrow indicates hybrid joint product.
(F) PCR strategy to detect endogenous Vk6-23 to Jk1 coding joints (CJ) and hybrid joints (HJ) in (i) control and Setd2-
deficient v-Abl lines treated for 72 h with STI-571 G ATMi and (ii) Setd2f/f and Setd2D/D splenocytes. Il-2 gene PCR was
used as a loading control and analyzed and quantified by high-sensitivity TapeStation (D1000). Blue arrow indicates CJ
product, and red arrow indicates HJ product.
See also Figures S6–S9.





























































































































































































































































































Figure 6. Loss of Setd2/H3K36me3 Reduces CDR3 Repertoire and Variable Gene Usage in proB Cells
(A) PCR and next-generation sequencing (NGS) strategy of V(D)J recombination products of VH families to JH4; 500-bp
product (blue box) was extracted and submitted for NGS amplicon sequencing. Sequencing was analyzed with MiXCR T/
B cell repertoire software (Bolotin et al., 2017).
(B) (i) Number of unique CDR3 clones, (ii) fraction and total clone counts by amino acid length, (iii) number of N-nucleotide
additions, (iv) total nucleotide deletions of CDR3s recovered, and (v) total sequencing reads of Setd2D/D (KO) and
controls for each VH family. proB cells were sorted from n = 4 for each genotype and subjected to NGS analysis.
Significance measured by Wilcoxon rank-sum test.
RNA sequencing analysis of four independently sorted control and four Setd2D/D proB cell compartments was also
conducted, and de novo assembly of CDR3 sequences was conducted using the TRUST algorithm (Li et al., 2017; Hu et al.,
2018, 2019). (C) Unique CDR3 counts for heavy and light chain Ig loci from TRUST analysis.
(D) Estimated B cell fraction of reads and B cell diversity recovered from analysis of RNA transcripts from TRUST analysis.
Estimate B cell fraction was calculated by taking the fraction of number of reads mapped to BCR(IGV/IGJ/IGC) region to
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treated with ATMi (Zha et al., 2011; Lescale et al., 2016) and suggests a functional redundancy between
Setd2/H3K36me3 and Atm kinase activity in ensuring proper repair. To investigate potential effects on
repair, we conducted Southern blotting, which revealed pMG-INV SJ and CJ formation without obvious
accumulation of free unrepaired SEs and CEs in STI-treated WT and Setd2/ v-Abl B cells (Figures 5D
and S8B). Thus, like Xlf, Mri, and Atm, Setd2 is not essential for C-NHEJ during V(D)J recombination
(Bredemeyer et al., 2006; Zha et al., 2011; Hung et al., 2018). The non-essentiality of Setd2/H3K36me3
for end-joining was further intimated by the inability of dual loss of Setd2/H3K36me3 and p53 to generate
translocations leading to the development of proB-cell lymphomas (Figures S9A and S9B), unlike loss of
core C-NHEJ factors in a p53-null background (Difilippantonio et al., 2000; Gao et al., 2000; Frank et al.,
2000).
Despite not being required for end-joining, ATMi-treated Setd2/ v-Abl cells exhibited significantly
increased mis-repaired recombination products that corresponded to either repaired SJs but unrepaired
CEs (SJ +CE) (Figures 5A, 5D(i-ii), and S8B) or the formation of hybrid joins (Figures 5A, 5D(i), and S8B), prod-
ucts consistent with the observed loss of GFP signal. The enhanced formation of HJs with loss of Atm kinase
activity and Setd2was further corroborated by the increased detection of aberrant HJ products of the pMG-
INV substrate in ATMi-treated Setd2/ cells (Figure 5E). Although we could detect evidence of HJ forma-
tion by PCR of the recombination substrate in Setd2/ lines without ATMi (Figure 5E), these products were
below detection by Southern blotting (Figures 5D(i) and S8B), but consistent with the modest decrease in
GFP signal with STI treatment alone (Figures 5B and 5C). Furthermore, we could detect HJ formation not
only from the endogenous k light chain locus of v-Abl Setd2 knockout cells but also in Setd2D/D splenocytes
(Figure 5F). Together, these data indicate a novel role for Setd2/H3K36me3, especially in combination with
Atm kinase activity, in the repair phase of V(D)J recombination to ensure proper joining.
Loss of Setd2/H3K36me3 Reduces Overall B Cell Repertoire
Even without loss of Atm kinase activity, however, there was abundant evidence of aberrant and abnormal rear-
rangement of the endogenous Igh locus in primary Setd2D/D proB cells (Figures 4F and S5E). We sequenced a
similarly sized recombinationproduct, present in both control and Setd2D/DproB cells, for three different heavy
chain Variable gene families joined to the JH4 fragment and found additional abnormalities (Figure 6A). Loss of
Setd2/H3K36me3 not only reduced the overall number of unique productive Igh rearrangements (assessed by
the number of unique hypervariable complementarity defining region-3 [CDR3]) but also resulted in shortening
ofCDR3 lengthand reductions inN-nucleotideadditions (Figures 6Aand6B) (Bolotin etal., 2017). Similarly,when
we looked at RNA-based transcripts of productive rearrangements of the Igh locus in proB cells using the hyper-
variable region calling algorithm TRUST (Li et al., 2017; Hu et al., 2018, 2019), Setd2D/D proB cells exhibited sig-
nificant decreases in detectable unique CDR3 sequences and an overall decrease in overall B cell repertoire di-
versity (Figures 6Cand6D). Furthermore,global variable and joininggeneusagewas reduced (Figure6E) inproB
cells from Setd2D/Dmice and coincided with evidence of increased clonality in variable gene usage, which did
not appear tobedependent on theproximity to theDiversity and Joininggenesegment regionson the Igh locus
(Figure 6F). These observations indicate that, in addition to its rolewithAtmduring end-joining to ensure appro-
priate repair, Setd2/H3K36me3 is also involved in othermechanisms that preventmis-processing andmis-repair
of brokenDNA ends to ensure the fidelity of V(D)J recombination and is critical inmaintaining a normal immune
repertoire.
Setd2/H3K36me3 Prevents Post-mitotic Neuronal Apoptosis and Perinatal Lethality
As Setd2/H3K36me3 seemed to be important for V(D)J recombination, we next wondered if it could play a
role in Rag-independent C-NHEJ repair. To first test this, we assessed the sensitivity of asynchronous WT
and Setd2/ v-Abl cells to ionizing radiation and found that Setd2/ v-Abl lines were more sensitive to
DSBs induced by ionizing radiation (Figure 7A(i)). This increased sensitivity to ionizing radiation of
Figure 6. Continued
total read count. B cell diversity was calculated by determining the ratio of unique CDR3 count over the total number
of reads mapped to BCR region.
(E) Variable (V) and Joining (J) gene usage for (i) heavy chain and (ii) kappa light chain from TRUST analysis. Boxplots
with SD.
(F) Clonality of CDR3s plotted as a fraction of total reads and ordered by individual Variable gene families and distance
from Diversity (D) and Joining gene loci from most proximal to most distal from right to left from TRUST analysis. Relative
size of clone indicated by size of dot.





Figure 7. Post-mitotic Neuronal Apoptosis and Perinatal Lethality with Loss of Setd2/H3K36me3
(A) (i) Asynchronous and (ii) STI-571 G1-arrested WT, Xrcc5, and two different Setd2/ v-Abl cells subjected to different
doses of ionizing radiation and serially diluted five times in triplicate to assess survival. Values plotted as a mean of each
dose as a percent of non-irradiated controls; bars represent standard deviation. Data are representative for three
different independent treatment experiments. Viability was assessed at 72 h. No viable cells were detected beyond the
0.5 Gy dose for G1-arrested Xrcc5 v-Abl clones.
(B) Expected and observed genotype distributions of matings between Nestin-cre Setd2D/+ mice to Setd2f/+ mice
(n = 15 litters) and Nestin-cre Setd2D/+ mice to Setd2f/f mice (n = 16 litters) 21 days post-partum (dpp).
(C) Embryo genotypes at different embryonic stages (n = 5 litters for each stage).
(D) Litter sizes of E14.5, E16.5, E18.5, and 0.25 dpp from Nestin-cre Setd2D/+ mice to Setd2f/f breedings. Significance to
0.25 dpp was measured (n = 5 litters for each stage except 0.25 dpp, n = 11).
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Setd2-deficient cells, at levels even greater than that of core NHEJ factors Xrcc5 (Ku80) and Lig4 (Fig-
ure 7A(i) and Figure S10A), could be in part due to previously described roles in HR-mediated DSB repair
ascribed to Setd2/H3K36me3 (Li et al., 2013; Pfister et al., 2014; Aymard et al., 2014). To exclude the effects
that may be driven by cells that may be cycling, we chose to study the sensitivity of G1-arrested v-Abl cells
by inhibition with STI-571 or the Cdk4/6 inhibitor PD0332991 for 48 h before exposure to ionizing radiation.
In both cell-cycle-arresting conditions, G1-arrested Setd2/ v-Abl cells exhibited increased sensitivity
cells to DSBs induced by ionizing radiation compared with WT controls (Figures 7A(ii), S10B, and S10C).
Together, these data suggest that Setd2/H3K36me3 is important in the DSB repair in the G1 phase of
cell cycle.
In addition to lymphogenesis, core C-NHEJ factors are critical for enforcing normal neurogenesis, where
differentiating post-mitotic neurons migrating out of the ventricular zone do not have HR available for
repair of DNA DSBs and instead rely on C-NHEJ (Frappart and McKinnon, 2008). Given our findings for
a role for Setd2/H3K36me3 in the repair phase of V(D)J recombination, we tested its potential functions
in neurogenesis. Consistent with the defective CNS development and embryonic lethality observed in
knockout mouse models of core C-NHEJ factors (Gao et al., 1998; Frank et al., 2000; Gu et al., 2000), we
observed post-mitotic neuronal apoptosis and perinatal lethality in mice with homozygous deletion of
Setd2 in neural progenitor-restricted Nestin-cre-expressing mice, where deletion has been demonstrated
to occur before post-mitotic neurogenesis (Liang et al., 2012). The severity of this phenotype is demon-
strated by the complete absence of Nestin-cre Setd2D/D pups at 21 days post-partum (dpp) (Figures 7B
and 7C) with perinatal lethality by 0.25 dpp (Figure 7D). Histopathological analysis of embryos revealed
evidence of apoptosis of post-mitotic neurons as early as E14.5 (Figures S11A and S11B), as well as
more widespread apoptosis in the developing brain in E18.5 embryos and in 2-h post-partum pups (Figures
7E, 7F, S11C, and S11D) suggesting a role for Setd2/H3K36me3 in embryonic neurogenesis that is reminis-
cent of deficiency for C-NHEJ factors.
DISCUSSION
The preservation of a genome is predicated on proper repair of DNA DSB and a balance between HR,
which is a highly accurate and also slower form of repair that is restricted to the availability of a sister chro-
matid strand, and NHEJ, which is highly efficient but intrinsically error prone (Takata et al., 1998). Although
there have been some studies highlighting the importance of chromatin accessibility, nucleosome posi-
tioning, DNA looping, and recognition of histone modifications (e.g., H3K4me3 by RAG2) (Shimazaki
and Lieber, 2014; Johnson et al., 2010; Bettridge et al., 2017; Matthews et al., 2007; Matheson and Cor-
coran, 2012) in the regulation of the V(D)J recombination process and phosphorylation of gH2AX in repair
(Yin et al., 2009; Celeste et al., 2003), little has been described in terms of the impact of other chromatin
modifications, especially in the end-joining phase of the V(D)J recombination reaction.
Here, wediscovered a strongdependencyof normal hematopoiesis and, in particular, lymphogenesis onSetd2/
H3K36me3 phenotypes consistent with previously published reports of three distinctly engineered knockout
mouse models (Zhou et al., 2018; Zhang et al., 2018; Ji et al., 2019). Early loss of Setd2/H3K36me3 leads to
severely impaired B and T cell development that could be partially rescued, in the case of B lymphogenesis,
with the expression of a fully rearranged Igh locus, pointing to a role for Setd2/H3K36me3 in V(D)J recombina-
tion. This role of Setd2 in V(D)J recombination is further corroborated by the partial rescue of T lymphopoiesis
with the over-expression of a rearranged TCR in Lck-cre Setd2D/D mice (Ji, et al., 2019). Ji et al. also report
decreased Rag1 occupancy across the Igh locus in B220+Cd19+ cells from Cd19cre Setd2D/D mice (Ji et al.,
2019), including at variable region family genes. In sorted proB cells (B220+Cd43+IgM) where we induced
loss of Setd2/H3K36me3 early in hematopoiesis, however, we could not detect a significant effect on the recruit-
ment of Rag1 to the critical regulatory region nearwhere theEm enhancer resides andwhere Rag1 has previously
been shown to bind in vivo at the proB cell stage of development (Ji et al., 2010). The observed Rag1 occupancy
differences observed by Ji et al., (2019) in populations of lymphoid cells are likely impacted by their inclusion of
Figure 7. Continued
(E) Cleaved caspase 3 immunohistochemistry of E18.5 embryos. Sagittal sections show staining of regions of the
diencephalic, telencephalic, and mesencephalic regions with magnifications indicated by corresponding colored boxes.
(F) TUNEL assay of 2-h post-partum control and Nestin-cre Setd2D/D pups. Coronal sections of the lateral ventricle with
magnifications indicated by corresponding red and green boxes.
**p < 0.01 ***p < 0.001, error bars represent SD. See also Figures S10 and S11.
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more mature B cell populations (B220+Cd19+ includes Cd43+ late proB andmore mature Cd43-preB cells) that
are depleted in Setd2D/Dmice, as well as by incomplete and leaky deletion of Setd2 via the use cre-expressing
mouse lines (Cd19cre) that delete after the proB cell developmental stage of interest (Rickert et al., 1997;
Hobeika et al., 2006; Kraus et al., 2004; Siegemund et al., 2015).
We wanted to understand the nature of the defect in repair with early loss of Setd2 in proB cells, especially
with respect to end-ligation, as we could not detect significant differences in the initiation phase of V(D)J
recombination and as we could detect recombination of the Igh locus, albeit abnormal recombination. We
therefore turned to an inducible system to measure the repair defect and uncovered new roles for Setd2/
H3K36me3 in the fidelity of the V(D)J recombination reaction, especially in combination with ATM kinase
activity. We determined that Setd2/H3K36me3 is not absolutely required for end-ligation by the lack of
detectable unrepaired CEs and SEs of an ectopically integrated recombination substrate, pMG-INV.
This non-essentiality for repair is consistent with our ability to detect recombination products in proB cells
of Setd2D/D mice, albeit abnormal ones, and the lack of proB lymphomas as a consequence of transloca-
tion events in dual Setd2D/D p53D/D mice. It is noteworthy that unlike dual loss of ATM and XLF, loss of
Setd2/H3K36me3 and Atm kinase activity did not result in complete abolishment of proper end-joining,
but did lead to increased abnormal joining (e.g., SJ + CE joins and HJs), suggesting that Setd2/
H3K36me3’s role in end-ligation is functionally distinct from C-NHEJ XRCC4 paralogs XLF and PAXX (Les-
cale et al., 2016; Kumar et al., 2016). Although we could detect robust and efficient conversion of fully and
properly recombined SJ + CJ products of the pMG-INV recombination substrate in induced Setd2-defi-
cient v-Abl cells, we could also detect, with combined loss of Atm kinase activity, an aberrant SJ + CE
recombination product. This raises the possibility of a CE-specific hairpin opening/repair defect, which
would certainly require further study as CEs are thought be efficiently processed and repaired at a much
higher rate than SEs and CE-only defects have not previously been reported (Ramsden and Gellert,
1995; Schlissel et al., 1993; Roth, et al., 1992; Canela et al., 2016; Meek et al., 2016).
Paradoxically, whereas the end-ligation defect of Setd2/H3K36me3 loss, as determined by the assessment
of a recombination substrate in transformed v-Abl cells, may appear subtle, in mice, its loss severely arrests
normal B/T lymphocyte development, similar to what is observed in mice with loss of C-NHEJ factors (Alt
et al., 2013; Kumar et al., 2014) and in contrast to loss of factors involved in end-ligation, such as Atm, Xlf,
Paxx, or Mri individually (Bredemeyer et al., 2006; Kumar et al., 2016; Hung et al., 2018; Li et al., 2008; Les-
cale et al., 2016; Zha et al., 2011). This difference suggests that there are other determinants that contribute
to the severe block in B (and T) lymphoid development in Setd2 knockout mice. For example, certain factors
present at the Igh locus in proB cells may not be fully recapitulated in the assessment of rearrangement of
an ectopic recombination substrate in transformed v-Abl cells, potentially affecting both the efficiency and
accuracy of repair.
Likewise, it is also possible that there are other roles of ATM, or ATM targets, and SETD2 in end-joining that
are not directly related and are mediated by distinct processes that, when combined, exacerbate
mis-repair overall. Specifically, the loss of Setd2/H3K36me3 could influence the recruitment of factors asso-
ciated with NHEJ in DNA DSB that recognize H3K36me3 (e.g., PHRF1 and PHF1) that could impact end-
joining efficiency (Chang et al., 2015; Hong et al., 2008; Musselman et al., 2012), rather than playing a direct
role in the stabilization of broken chromosomal ends, a function that has been ascribed to ATM (Brede-
meyer et al., 2006). Additionally, we did not find any overt gene expression differences in alternative-
NHEJ (A-NHEJ) factors and were not able to detect higher rates of deletions or translocations thought
to accompany some forms of this A-NHEJ (Corneo et al., 2007) in either our CDR3 repertoire analysis, prod-
ucts of recombination of the recombination substrate in v-Abl cells, or in mice with dual loss of Setd2 and
p53. These correlative lines of evidence however, do not fully preclude the possibility of rare forms of A-
NHEJ contributing to the observed phenotype, warranting further investigation.
When we examined the abnormal recombination in proB cells of Setd2D/Dmicemore closely, we addition-
ally noted significant loss of B cell repertoire and reduction of variable gene usage, characterized by less
diversity in re-arranged, productive CDR3 sequences, as well as other abnormalities. Shortening of CDR3
length, without concomitant reduction of immune repertoire, has been previously connected to end-liga-
tion factor, XLF (IJspeert et al., 2016). In addition, shortening of CDR3 sequences of Ig heavy chain rear-
rangements has previously been observed in Pol X family knockouts (pol l, m), which with terminal deoxy-
nucleotidyl transferase participates in nucleotide end-processing of heavy chain junctions during V(D)J
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recombination (Bertocci et al., 2006). Thus, it is possible that Setd2/H3K36me3 may play additional roles in
the end-processing of junctions, in addition to preventing the mis-repair in end-ligation we observed.
We also found that loss of Setd2/H3K36me3 increases sensitivity of cells to DSBs induced by ionizing radi-
ation in both asynchronous and G1-arrested v-Abl cells, suggesting that Setd2/H3K36me3 may play a role
in DSB repair activities in cells where HR would not be available, due to the lack of a sister chromatid. This
result seemed to be supported by our discovery that neural-specific deletion of Setd2/H3K36me3 resulted
in post-mitotic neuronal apoptosis. Although it is possible that other factors may be contributing to the
neurogenesis defect, the temporal and spatial localization of apoptotic neuronal cells are highly sugges-
tive of a role for Setd2/H3K36me3 in post-mitotic neurogenesis. The perinatal lethality we observed inNes-
tin-cre Setd2D/D mice is in stark contrast to Nestin-cre-driven conditional loss of core C-NHEJ factors,
Xrcc4 or Lig4, where mice survive to adulthood (Frappart et al., 2009; Yan et al., 2006). Instead, it parallels
the severity of the developmental arrest we observed in lymphogenesis, despite Setd2/H3K36me3 not
being essential for C-NHEJ repair.
Previous studies have indicated a role for H3K36me3 in not only the recruitment of components on DNA
damage repair in both MMR (MSH2/6) (Li et al., 2013) and HR (CtIP) (Pfister et al., 2014; Aymard et al.,
2014) but also a role in a myriad of other cellular processes (Wagner and Carpenter, 2012). Although we
have not exhaustively ruled out every potential role of Setd2/H3K36me3 in DSB repair, transcription,
and splicing, we have attempted to study the role of Setd2/H3K36me3 in two systems that utilize NHEJ-
mediated DSB repair by taking advantage of the non-redundancy of Setd2 in two independent mammalian
developmental processes. Given the high frequency of SETD2mutations in B and T cell lymphomas (Parker
et al., 2016; Zhang et al., 2012; McKinney et al., 2017; Moffitt et al., 2017), primary human immunodeficiency
(Ji et al., 2019), and neurological/developmental disorders (e.g., autism, intellectual disability, high-grade
pediatric glioma) (Fontebasso et al., 2013; D’Gama et al., 2015; Tlemsani et al., 2016; Lelieveld et al., 2016),
our findings demonstrating a role of Setd2/H3K36me3 in normal lymphogenesis and neurogenesis are
especially noteworthy.
Limitations of Studies
Limitations of our studies include our inability to assess localization of critical NHEJ factors (e.g., Rag2,
Ku70, Ku80, Xrcc4, Lig4, and others) due to the lack of readily available antibodies to perform ChIP of these
proteins. In addition, although the use of v-Abl-transformed late-proB cell lines with an ectopically
expressed recombination substrate can determine the essentiality of factors for end-joining in NHEJ,
the use of such a system fails to recapitulate the factors or genomic structure present at the endogenous
immunoglobulin loci, which may also influence the V(D)J recombination process during early lymphocyte
development. Thus, it is possible that the severity of the block in normal lymphocyte development
observed in vivo could be influenced by factors and mechanisms beyond the role of Setd2/H3K36me3 in
end-joining during the repair phase of V(D)J recombination. Also, we were unable to assess if there was
a non-enzymatic role for the Setd2 protein itself in any of the NHEJ processes in lymphocyte development,
as expression of a full-length Setd2 (2,500 amino acids, 8-kb nucleotide coding sequence) in primary
murine cells was unable to be achieved (by us and also not reported by other groups with genetically
engineered Setd2 knockout mouse models, including but limited to Zhou et al., 2018; Zhang et al., 2018;
Ji et al., 2019). We also did not fully and exhaustively investigate the role of A-NHEJ factors or the potential
contribution of other roles that Setd2 and H3K36me3 play in normal cellular processes in both V(D)J recom-
bination or post-mitotic neurogenesis settings.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
DATA AND CODE AVAILABILITY
RNA-seq, ATAC-seq, ChIP-seq, TRUST, and MIXCR data generated and analyzed during the current study
have been deposited into the National Center for Biotechnology Information (NCBI) Gene Expression
Omnibus (GEO). The accession numbers for the RNA-seq, ATAC-seq, ChIP-seq, TRUST, and MIXCR
data reported in this paper are GSE130904, GSE131588, GSE131608. These are unified under SuperSeries
GSE131690.
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K., et al. (2016). Meta-analysis of 2,104 trios
provides support for 10 new genes for intellectual
disability. Nat. Neurosci. 19, 1194–1196.
Lescale, C., Abramowski, V., Bedora-Faure, M.,
Murigneux, V., Vera, G., Roth DB, D.B., Revy, P.,
de Villartay, J.P., and Deriano, L. (2016). RAG2
and XLF/Cernunnos interplay reveals a novel role
for the RAG complex in DNA repair. Nat.
Commun. 7, 10529.
Li, B., Li, T., Wang, B., Dou, R., Zhang, J., Liu, J.S.,
and Liu, X.S. (2017). Ultrasensitive detection of
TCR hypervariable-region sequences in solid-
tissue RNA–seq data. Nat. Genet. 49, 482–483.
Li, F., Mao, G., Tong, D., Huang, J., Gu, L., Yang,
W., and Li, G.M. (2013). The histone mark
H3K36me3 regulates human DNA mismatch
repair through its interaction with MutSa. Cell
153, 590–600.
Li, G., Alt FW, F.W., Cheng, H.L., Brush, J.W.,
Goff, P.H., Murphy, M.M., Franco, S., Zhang, Y.,
and Zha, S. (2008). Lymphocyte-specific
compensation for XLF/cernunnos end-joining
functions in V(D)J recombination. Mol. Cell 31,
631–640.
Liang, H., Hippenmeyer, S., and Ghashghaei, H.T.
(2012). A Nestin-cre transgenic mouse is
insufficient for recombination in early embryonic
neural progenitors. Biol. Open 1, 1200–1203.
Lu, C., Jain, S.U., Hoelper, D., Bechet, D., Molden,
R.C., Ran, L., Murphy, D., Venneti, S., Hameed,
M., Pawel, B.R., et al. (2016). Histone H3K36
mutations promote sarcomagenesis through
altered histone methylation landscape. Science
352, 844–849.
Mar, B.G., Chu, S.H., Kahn, J.D., Krivtsov, A.V.,
Koche, R., Castellano, C.A., Kotlier, J.L., Zon, R.L.,
McConkey, M.E., Chabon, J., et al. (2017). SETD2
alterations impair DNA damage recognition and
lead to resistance to chemotherapy in leukemia.
Blood 130, 2631–2641.
Matheson, L.S., and Corcoran, A.E. (2012). Local
and global epigenetic regulation of V(D)J
recombination. Curr. Top. Microbiol. Immunol.
356, 65–89.
Matthews, A.G., Kuo, A.J., Ramón-Maiques, S.,
Han, S., Champagne, K.S., Ivanov, D., Gallardo,
M., Carney, D., Cheung, P., Ciccone, D.N., et al.
(2007). RAG2 PHD finger couples histone H3
lysine 4 trimethylation with V(D)J recombination.
Nature 450, 1106–1110.
McKinney, M., Moffitt, A.B., Gaulard, P., Travert,
M., De Leval, L., Nicolae, A., Raffeld, M., Jaffe,
E.S., Pittaluga, S., Xi, L., et al. (2017). The genetic
basis of hepatosplenic T-cell lymphoma. Cancer
Discov. 7, 369–379.
Meek, K., Xu, Y., Bailie, C., Kefei, Y., andNeal, J.A.
(2016). The ATM kinase restrains joining of both
VDJ signal and coding ends. J. Immunol. 197,
3165–3174.
Moffitt, A.B., Ondrejka, S.L., McKinney, M.,
Rempel, R.E., Goodlad, J.R., Teh, C.H., Leppa, S.,
16 iScience 23, 100941, March 27, 2020
Mannisto, S., Kovanen, P.E., Tse, E., et al. (2017).
Enteropathy-associated T cell lymphoma
subtypes are characterized by loss of function of
SETD2. J. Exp. Med. 214, 1371–1386.
Musselman, C.A., Avvakumov, N., Watanabe, R.,
Abraham, C.G., Lalonde, M.E., Hong, Z., Allen,
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(i) (ii) (iii) (iv)
Figure S1. Loss of Setd2/H3K36me3 disrupts normal hematopoiesis, Related to Figure 1
(A) CBC and differentials from Setd2Δ/Δ, Setd2Δ/+ and controls (Setd2f/f) (n>3 for all groups) *, p<0.05 **, 
p<0.01 ***, p<0.001 (B) (i) total cellularity of spleen, thymus, whole bone marrow and lineage negative BM, 
total cellularity of cells positive for differentiated markers B220, Cd3, Mac1, Gr1, or Ter119 in (ii) bone marrow 
or (iii) spleen and (iv) spleen and thymus weights for heterozygous Setd2 mice and controls (n= 3 for all 
groups).  All values were non-significant.  (C) Representative flow cytometry plot of HSC fractions, multipotent 
primed progenitors (MPP1-4) and percent composition of lineage negative cells of HSC stem cell and 
progenitor populations (n= 10 for all groups).  (D) Representative flow cytometry plots for early myeloid and 
erythroid progenitor populations in bone marrow.  MkP: KithiSca1-Cd41+Cd150+, GMP: KithiSca1-Cd41-Cd150-
FcγRII/III+, pre-GM: KithiSca1-Cd41-FcγRII/III-Cd150-Endoglin-, pre-CFU-E: KithiSca1-Cd41-FcγRII/III-
Cd150+Endoglin+, pre-MegE: KithiSca1-Cd41-FcγRII/III-Cd150+Endoglin- and proportion of HSC and erythroid 
progenitor populations of control and Setd2Δ/Δ (n = 7 for all groups).  (E) Representative flow cytometry of 
erythroid progenitor populations. proE, 1-Basophilic erythroblasts (Baso-E), 2-late Baso-E and chromatophilic 
erythroblasts (Poly-E), and 3-orthochromatophilic erythroblasts (Ortho-E) in control and Setd2Δ/Δ bone 
marrow.  (F) Percent composition of different erythroid progenitor populations in bone marrow and spleen of 
control and Setd2Δ/Δ mice (n = 3). *, p<0.05 **, p<0.01 ***, p<0.001, error bars represent SD.
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Figure S2. Setd2Δ/Δ HSCs are defective in competitive and non-competitive bone marrow (BM) 
reconstitution assays, Related to Figure 1
(A) (i) Peripheral blood engraftment, as measured by Cd45.2+ of competitive reconstitution of lethally irradiated 
(9cGy) recipient mice with 1x106 WBM Mx1 Setd2Δ/Δ and control bone marrow with 1x106 WBM from 
syngeneic Cd45.1+ mice after induction of Mx1-cre with polyI:polyC (pIpC).  (ii) Total BM cellularity of mice 16 
weeks after induction with pIpC (iii) percent Cd45.2 involvement in BM, spleen and peripheral blood, (iv) total 
cell counts of Cd45.2+ donor HSC stem and progenitor populations. (B) Non-competitive reconstitution assay 
as conducted in (A) without 1x106 Cd45.1+ wildtype competitor WBM cells.  Arrows indicate when pIpC
treatment was initiated.  (ii-iv) graphs were generated from mice 28 days post pIpC induction as Setd2Δ/Δ mice 
were moribund due to complete BM failure. (C) Competitive and non-competitive reconstitution of lethally 
irradiated (9cGy) recipient mice with 1x106 WBM Vav-cre Setd2Δ/Δ and control BM with 1x106 WBM from 
syngeneic Cd45.1+ mice.  Overall peripheral blood Cd45.2 chimerism in (i) competitive and (ii) non-competitive 
reconstitution assays.  (iii) total cellularity of Cd45.2+ whole and lineage negative BM (iv) Cd45.2+ chimerism (v) 
percentage and total numbers of Cd45.2+ donor derived HSC of competitive and non-competitive transplants 
16 weeks post-transplant (D) Competitive and non-competitive reconstitution of lethally irradiated recipient mice 
with 1x106 WBM Vav-cre Setd2Δ/Δ and Vav-cre Setd2Δ/+ control BM with 1x106 WBM from syngeneic 
Cd45.1+ mice.  (i) Overall peripheral blood Cd45.2+ chimerism and (ii) BM Cd45.2+ chimerism in competitive 
and non-competitive reconstitution assays 16 weeks post-transplant. All data is representative of at least 3 
independent transplant experiments. n = 5 for each transplant group. *, p<0.05 **, p<0.01 ***, p<0.001, error 
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Figure S3. Loss of Setd2/H3K36me3 arrests development at a proB cell stage, Related to Figure 3. 
(A) Representative flow cytometry plots with gating strategy for different B cell progenitor populations for 
controls and Setd2Δ/Δ B220+ BM cells. Fraction A (FrA): B220+IgM-Cd43+Cd19-Cd24loCd25; pre-proB: 
B220+IgM-Cd43+Cd19+Cd24loCd25-, proB: B220+IgM-Cd43+Cd19+Cd24hiCd25-; FrC’: B220+IgM-
Cd43+Cd19+Cd24hiCd25+; preB: B220+IgM-Cd43-; immature B: B220+Cd43-IgM+. (B) Percent composition of 
B220+ WBM of different B cell population in the bone marrow (n = 6). (C) B cell progenitor proportions in 
B220+ BM of Setd2Δ/Δ and controls (n= 14 for all groups). (D) Total cellularity of B cell progenitor 
proportions in B220+Cd43+IgM- BM of Setd2Δ/Δ and controls. n= 9 for all groups. (E) Ratio of preB to proB
compartment and DN4 to DN3 compartment total cellularity from BM of Setd2Δ/Δ and controls (n= 8 for all 
groups, from Fig. 3A-B)  (F) Quantification of phospho-gH2ax foci by immunofluorescence from sorted FrA
proB cells from Setd2Δ/Δ (n=8 mice) and controls (n=7 mice).  (i) Fraction of total cells containing foci 
(n=366 for Setd2Δ/Δ, n= 337 for controls). (ii) Foci/cell in cells containing phospho-gH2ax foci (n=260 for 
Setd2Δ/Δ, n= 191 for controls). (iii) Frequency of foci/cell for all cells containing phospho-gH2ax foci for 
Setd2Δ/Δ and controls.  (G) percent of different B cell populations positive for phospho-gH2ax by flow 
cytometry (n=15 for Setd2Δ/Δ, n=13 for controls).  All groups were significant (p<0.01) except for preB
population.  (H) Representative flow cytometry plot of cell cycle status indicated by co-staining with DAPI 
and BrdU incorporation of sorted FrA proB cells from Setd2Δ/Δ (n=3) and controls (n= 2) and summary 
graph of each cell cycle stage.  All values for cell cycle status were non-significant.   **, p<0.01 ***, p<0.001, 
error bars represent SD.






































































































































Figure S4. Loss of Setd2/H3K36me3 does not alter expression of C-NHEJ and A-NHEJ proteins, 
Related to Figure 3.
(A) Volcano plot of fold expression of a FrA proB cell compartment sorted from n=3 independent 
Setd2Δ/Δ and littermate control mice and subjected to by RNA-Sequencing.  Genes highlighted include: 
Rag1, Rag2, Xrcc4, Lig4, Xrcc5, Xrcc6, Xrcc7, Prkdc, Hmgb2, Mre11a, Dclre1c, Atm, Parp1, Polq, Brca2, 
Ctbp1, Rad52, Mrnip.  (B) Real-time PCR of C-NHEJ and A-NHEJ genes of FrA proB cells sorted from 
n=2 Setd2Δ/Δ mice and a littermate control.  Expression was normalized to Gapdh expression and 
calculated relative to the wildtype control by a DDCt method.  (C) (i-v) Immunoblotting of FrA proB cells 
sorted from n=3 Setd2Δ/Δ mice and n=3 littermate controls (Setd2f/f) for C-NHEJ proteins Ku70, Ku80, 
Xrcc4, Rag1, Rag2, Hmgb2 with loading controls Vinculin and Gapdh.  Mb – low molecular weight ladder, 
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Figure S5. Loss of H3K36me3 does alter local chromatin architecture or accessibility of the Igh locus 
but leads to aberrant V(D)J recombination, Related to Figure 4.
(A) Composite Heatmap and volcano plot of H3K36me3 ChIP-Seq signal of Cd19- and Cd19+ control (WT) 
and Setd2Δ/Δ (KO) proB cells (B220+Cd43+IgM-) (n=3 for each genotype). (B) ATAC-sequencing tracks from 
Cd19- and Cd19+ control (WT) and Setd2Δ/Δ (KO) proB cells (B220+Cd43+IgM-) (n=2 for each genotype) 
across the Igh locus.  (C) Representative ChIP-PCR of relative abundance of H3K36me1-3 and H3K27me1-3 
at regulatory region of Igh locus.  Regions R1-R5 were regions with H3K36me signal in between the Eμ
enhancer binding site and Cμ gene region with HoxA9, Cγ3 and actin as controls. Data is representative of n 
= 2 independent experiments.  (D) (i-iii) H3K36me3, H3K4me3, and H3K9ac ChIP-PCR of variable heavy 
chain gene families and from n=4 independent ChIP experiments and (iv) Rag1 occupancy by ChIP-PCR 
variable gene family genes with primers from (Ji et al 2019 and (Ji et al., 2010; Hauser et al., 2014; 
Subrahmanyam et al., 2012; Chakraborty et al., 2009; Hesslein, et al, 2003).  (n=1 ChIP). (E) (i-iii) replicates 
of PCR assay to detect V(D)J recombination products of rearrangement shown in Figure 2E of the Igh locus 
of different VH families from independently sorted proB cells from Setd2Δ/Δ (KO) and controls (WT).  No 





































































































































































Figure S6. Generation of v-Abl transformed Setd2, Xrcc5 and Lig4 deficient cell lines, Related to 
Figure 5.
(A) H3K36me3 levels of several individual v-Abl clones (used in Figure 5) that were either Setd2
wildtype (wt, indicated with asterisk) or Setd2 deficient lines (Setd2-/- or  KO).  Total H3 and Gapdh
were used as loading controls. (B) (i-ii) immunoblots of Setd2 wildtype or Setd2-/- v-Abl lines for Kmt3a 
(Setd2) and Vinculin loading controls. (C) Immunoblot of v-Abl lines for Xrcc5 (Ku80) null lines.  Gapdh
was used as a loading control.  (D) Representative flow cytometric analysis of GFP expression in Lig4
and Xrcc5-/- pMG-INV v-Abl cells treated with Abl kinase inhibitor imatinib (STI-571) and ATM kinase 




































































































































Figure S7. Deletion of Setd2 in v-Abl cells does not alter expression of C-NHEJ and A-
NHEJ proteins or cell cycle status, Related to Figure 5.
(A) (i-iii) Immunoblotting of WT and Setd2-/- v-Abl clones for C-NHEJ proteins Ku70, Ku80, 
Xrcc4, Rag1, Rag2, Hmgb2 with loading controls Vinculin and Gapdh.  Mb – low molecular 
weight ladder, Ms – high molecular weight ladder. (B) Real-time PCR of C-NHEJ and A-NHEJ 
genes of Setd2 deficient and WT v-Abl transformed cells.  Expression was normalized to Gapdh
expression and calculated relative to the wildtype control by a DDCt method.  (C) Representative 
flow cytometry plot of cell cycle status indicated by co-staining with DAPI and BrdU incorporation 
of Setd2 deficient and WT v-Abl cells.  All data representative of n=2 independent experiments. 
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Figure S8. Dual loss of Setd2/H3K36me3 and Atm activity leads to abnormal recombination and 
end-joining repair, Related to Figure 5.
(A) (i-iii) Immunoblotting for NHEJ proteins and phospho- and total gH2ax of WT (Setd2+/+) and Setd2 
deficient (Setd2-/-) v-Abl cells treated for 48 hours with STI or STI+ATMi.  Data representative of 3 
independent induction experiments.  Mb – low molecular weight ladder, Ms – high molecular weight 
ladder. (B) Replicate Southern blot analysis of genomic DNA from Setd2-/- clone (D10) and control line 
that were digested with NheI (left) and XbaI (middle and right panels) and hybridized with Thy1 probe 
(middle, right panels) or GFP probe (left panel).  Bands indicated are for URs, SJs, CJs, SEs, CJ+SEs or 
SJ+CEs. Hybrid Joins (HJ) indicated as well.  Southern blots were generated from an independent 
induction experiment of v-Abl clones with imatinib and ATMi shown in Figure 5.





















































































Figure S9. Dual loss of Setd2/H3K36me3 and p53 does not lead to the development of pro-
B lymphomas, Related to Figure 5.
(A) Kaplan-Meier survival of double knockout Vav (n= 1), Mx1 (n=7), Cd2 (n=4) , Mb1cre (n=9) 
Setd2Δ/Δ p53Δ/Δ mice and controls (n = 11).  All mice developed thymic lymphomas. (B) Weight 
of thymus in mouse thymic lymphomas from double knockout mice and controls. ***, p<0.001 

























Figure S10. Asynchronous and synchronous Setd2 deficient v-Abl cells exhibit increased 
sensitivity to ionizing radiation, Related to Figure 7.
(A) Asynchronous and STI G1-arrested WT, Lig4-/- and 2 different Setd2-/- v-Abl cells subjected 
to different doses of ionizing radiation and serially diluted 5 times in triplicate to assess survival.  
Values plotted as a mean of each dose as a percent of non-irradiated controls, bars represent 
standard deviation.  Data is representative for 3 different independent treatment experiments.  
Viability was assessed at 72 hours.  (B)  Representative flow cytometric analysis of cell cycle 
status as determined by DNA content with DAPI staining 48 hours after treatment with 1mM 
Cdk4/6 inhibitor PD0332991.  Data representative of n=3 independent experiments.  (C)
PD0332991 G1-arrested WT Setd2-/- v-Abl cells subjected to different doses of ionizing radiation 
and serially diluted 5 times in triplicate to assess survival.  Values plotted as a mean of each 
dose as a percent of non-irradiated controls, bars represent standard deviation.  Data is 
representative for 3 different independent treatment experiments.  Viability was assessed at 72 









































































Figure S11. Post-mitotic neuronal apoptosis with loss of Setd2/H3K36me3, Related to Figure 7.
(A,B) TUNEL assay of two independently matched control and Nestin-cre Setd2Δ/Δ E14.5 coronal sections 
of the lateral ventricle displaying the ganglionic eminence (GE), Lateral Ventricle (V), Ventricular zone and 
intermediate zone (IZ) of the telencephalon. Distances as indicated in microns. (C) Higher magnification of 
cleaved Caspase-3 immunohistochemistry of E18.5 sagittal regions of lateral ventricle of control and Nestin-
cre Setd2Δ/Δ embryos from Figure 7D. Distances as indicated in microns. (D) Cleaved caspase-3 
immunohistochemistry of coronal sections of the lateral ventricle of 2 hour post-partum control and Nestin-
cre Setd2Δ/Δ pups from same samples as shown in Figure 7E. Magnifications indicated by corresponding 
red and green boxes.  Arrows indicate cleaved caspase-3 staining and pyknotic nuclei.  Distances as 
indicated in microns.
Transparent Methods 
Mice and Isolation of primary B cells and v-Abl B cells  
Strategy for generating Setd2Δ/Δ mice was previously described (Mar et al., 2018).  
Setd2f/f mice were bred to Mx1, Vav1, Cd19, Mb1, hCD2-cre mice to homozygosity.  At 
6-8 weeks of age, mice were sacrificed and bone marrow from femurs, tibias, hips, and 
spines were isolated.  BM was then RBC lysed and stained with B220-biotin (BD 
Pharmingen) and subsequently stained with Anti-biotin microbeads (Miltenyi) and 
applied on a LS column (Miltenyi).  Subsequent staining for cellular antigens was 
conducted.  For V(D)J recombination product assessment, RNA-Seq, ChIP-Seq, ChIP-
PCR, and qPCR were stained and sorted by FACS (BD-Aria) for B220+Cd43+IgM-Cd25-
Cd19- proB cells and B220+Cd43-IgM- for preB. IgHelMD4 (Goodnow et al., 1988) and 
Mb1cre mice were generously provided by Jayanta Chaudhuri.  All mouse experiments 
were approved by the Institutional Animal Care and Use Committees at Dana-Farber 
Cancer Institute and Memorial Sloan Kettering Cancer Center. 
 
WT and Lig4-/- v-Abl B cell lines were generously provided by Andre Nussenzweig and 
Barry Sleckman (Bredemeyer et al., 2006).  Xrcc5 and Setd2 knockout v-Abl cells were 
generated as before (Bredemeyer et al., 2006; Jacobsen et al., 2006).  Briefly, CMV 
expression vectors containing Cas9 and a BFP tagged expression vector (Hung et al., 
2018) with sgRNAs targeting gene of interest were nucleofected with Amaxa 
nucleofection Kit P4 as per manufacturer’s instructions (Lonza).  Less than 24 hours 
later, BFP+ cells were single cell sorted into 96 well plates and expanded and western 
blotting was conducted to confirm protein knockout.  Single cell clones with confirmed 
knockout of protein were transduced with retrovirus containing pMG-INV (Hung et al., 
2018) vector and subsequently sorted for expression of cell surface marker Thy1.2.  
The recombination substrate vector pMG-INV was generously provided by Barry 
Sleckman. To induce G1 arrest, cells were treated with 3µM imatinib (STI571) with or 
without 15 µM ATMi (KU55933) for up to 96 hours and assayed for GFP expression by 
flow cytometry and genomic DNA isolation for downstream PCR analysis.  sgRNAs for 
CRISPR/Cas9 used were as follows: Xrcc5: sgXrcc5-1 (5’-
GAATGATATCACTTCCGTAG-3’), sgXrcc5-2 (5’-GAGCTTGGTAAAGAAAAACG-3’), 
sgXrcc5-3 (5’-GTCATAAGCATATCGGACGA-3’), sgXrcc5-4 (5’-
TGTCCTTAGAAGGCGAAGAC-3’), sgXrcc5-5 (5’-TGCACACAATCAGGGCGTCC-3’).  
Setd2: sgSetd2-1 (5’-GCATTCGCTTAATATCCCGG-3’), sgSetd2-2 (5’-
GGAGTTCCCCTTATCGTGAG-3’), sgSetd2-3 (5’-TTGCTTATGATCGAATCCAA-3’), 
sgSetd2-3 (5’-TGCTCATGCTCAGAGTGACG-3’), sgSetd2-5 (5’-
ATAATAGGGAGCCGACAGAC-3’). 
 
RNA-sequencing of LSK and proB cells 
B cells were isolated as indicated above.  LSKs were obtained by lineage depletion of 
WBM and conducted as per manufacturer’s protocols with biotin-labeled antibodies for 
CD3, Gr1, Ter119, and B220 (BD Pharmingen) and subsequently subjected to magnetic 
depletion with anti-biotin microbeads and depletion on a LD column (Miltenyi).  Lineage 
depleted cells were then stained with cKit and Sca1 and sorted on a FACS cell sorter 
(BD-SORP-AriaII).  Qiagen RNA kits were used as per manufacturer’s protocol for RNA 
isolation and purity was confirmed with RNA Tapestation (Illumina).  RNA-seq libraries 
were prepared with NEBNext UltraKits and for proB cells. For LSKs, RNA was amplified 
with SMARTer Ultra Low Input RNA Kit for Illumina Sequencing.   
 
Hematopoietic Reconstitution assays 
For competitive/non-competitive reconstitution assays, 1x106 total, unfractionated whole 
BM cells of control and fully excised Setd2 mice were injected into lethally irradiated 
mice (9 cGy) and bled every 4 weeks up to 16 weeks before these mice were sacrificed 
and hematopoietic reconstitution was assessed in the bone marrow.  Non-excised 
Mx1cre Setd2Δ/Δ mice were treated with pI:pC after 8 weeks of engraftment in 
reconstitution assays. 
 
BrdU incorporation assays 
For in vivo assessment of BrdU incorporation, BrdU was injected intraperitoneally 4 
hours before mice sacrificed and BrdU incorporation was assessed as per 
manufacturer’s protocols (BD Biosciences).  Recommended manufacturer’s protocols 
were also followed for in vitro labelling of v-Abl cells.  Cells were labelled for 2 hours 
before fixed and permeabilized. 
 
Phospho-gH2ax Immunofluorescence  
 
Cytospins of 20 000 sorted FrA proB cells were prepared at 500 rpm for 5 minutes, 
permeabilized and fixed in 4% paraformaldehyde/PBS at 4oC for 10 minutes. Phospho-
gH2AX (Abcam) primary antibody was used at 1:500 and incubated at 4oC overnight. 
Secondary antibody Anti-rabbit Alexa647 (CST) was applied for 30 minutes at room 
temperature. DAPI (1 µg/ml) counterstaining was conducted for 5 minutes at room 
temperature and covered with Prolong Gold Antifade Reagent (ThermoFisher). Slides 
were analyzed by confocal microscopy (Leica TCS SP5) (Leica) and foci were 
quantified using Image J software (NIH). 
 
Ionizing Radiation Sensitivity Assay 
Ionizing radiation sensitivity assays were performed for v-Abl lines that were either 
asynchronous or G1 arrested with STI-571 (Selleckchem) or PD-0332991 (Sigma-
Aldrich)  before irradiation. Cells were treated with 0.1, 0.5, 1, or 2.5 Gy ionizing 
radiation with percent survival measured relative to a non-irradiated and non-treated 
control for each cell line assayed.   Cells that were G1 arrested were treated 48 hours 
prior to irradiation before washing off medium containing 3µM STI571 or 1µM PD-
0332991 and re-plated with fresh media.  50,000 cells were initially plated in 96 non-
tissue culture treated plates and 1:1 serially diluted 5 times with 3 replicates for each 
condition and cultured at for 3 days.  Viability was measured by staining with DAPI and 
measured by flow cytometry on BD Fortessa in HTS mode.  
 
Genomic DNA isolation 
Up to 5x106 proB cells were harvested and genomic DNA extracted using PureLink 
Genomic DNA kit (Invitrogen) as per manufacturer’s protocols. 
 
PCR analyses 
PCR of retroviral substrate coding joints (CJs) and hybrid joints (HJs): pMG-INV was 
generously provided by Barry Sleckman (Hung et al., 2018).  Oligonucleotides CJ_F 
and CJ_HJ_R were used to amplify CJs in pMG-INV. Oligonucleotides HJ_F and 
CJ_HJ_R were used to amplify HJs.  CJ_F: (5’-TCAGCCAGAAATTCAGTGGCA-3’); 
HJ_F: (5’-TTGTACACCCTAAGCCTCCG-3’); CJ_HJ_R: (5’-
GCTTATCGATACCGTCGACCT-3’).  All PCRs were done on genomic DNA from cells 
that had been treated with STI571 for 96 hours. The Il2 gene was amplified using the 
IMR42 and IMR43 oligonucleotides (Bredemeyer et al., 2006). PCRs for the Il2 gene, 
and all retroviral HJs and CJs, were carried out in 50μL with cycling conditions of 95ºC 
for 2 minutes followed by 30 cycles 94ºC 30s, 55ºC 30s, 72ºC 60s (Bredemeyer et al., 
2006). Murine Il-2: forward (5’-CTAGGCCACAGAATTGAAAGATCT-3’); reverse (5’-
GTAGGTGGAAATTCTAGCATGATGC-3’) 
 
PCR analyses of endogenous receptor gene rearrangements: PCR of Vκ6-23 HJs and 
CJs was carried out by amplifying 0.5μg of genomic DNA from B220 enriched 
splenocytes from Setd2Δ/Δ and Setd2f/f controls in 50μl with primers for amplification 
as follows: pkJa and pk6a for HJ and pkJa and pk6d for CJ. PCR conditions were 95ºC 
for 5 minutes followed by 17 cycles 94ºC 30s, 64ºC 30s, 72ºC 30s. Products from this 
reaction were amplified in 50μl using the above conditions with primers pkJa and pk6b 
for HJ and pkJa and pκ6c for CJ and 25 amplification cycles oligonucleotides 




GGAGAGTGCCAGAATCTGGTTTCAG-3’).   
PCR results were analyzed with high sensitivity D1000 TapeStation reagents (Agilent 
Technologies). 
 
V(D)J recombination PCR: Assay was conducted as previously described (ten Boekel et 
al., 1995; Ehlich et al., 1994; Corcoran et al., 1998).  Briefly, two rounds of PCR were 
conducted on 100-300ng of gDNA using forward primers amplifying VH558, VHQ52, 
VH7183 family genes with nested primers located in the JH4 gene segment.  Products 
were visualized on a 1% agarose gel and the V-(D)JH4 recombination product was gel 










GGGTCTAGACTCTCAGCCGGCTCCCTCAGGG-3’); actin_738: forward (5’-
GGTGTCATGGTAGGTATGGGT-3’), reverse (5’-CGCACAATCTCACGTTCAG-3’). 
 
Chromatin Immunoprecipitation (ChIP) and ChIP-sequencing 
Chromatin immunoprecipitation was coupled with high-throughput sequencing (ChIP-
seq). 0.5-2x106 primary sorted proB cells were crosslinked with 1% formaldehyde for 10 
minutes followed by 0.125 M glycine for 5 minutes. Fixed cells were washed twice with 
ice-cold phosphate-buffered saline and resuspended in ChIP lysis buffer and sheared 
using a Covaris E220 ultrasonicator (Covaris).  Sheared chromatin was incubated 
overnight at 4oC with rabbit polyclonal anti-H3K36me3 (61101 pAb, Active Motif). 
Immune complexes were collected with protein A/G dynabeads (Invitrogen) and washed 
sequentially in low-salt wash buffer (20 mM Tris pH 8.0, 150 mM NaCl, 0.1% SDS, 1% 
Triton X-100, 2mM EDTA), high-salt wash buffer (20 mM Tris pH 8.0, 500 mM NaCl, 
0.1% SDS, 1% Triton X-100, 2mM EDTA), LiCl wash buffer (10 mM Tris pH 8.0, 250 
mM LiCl, 1% NP-40, 1% sodium deoxycholate, 1 mM EDTA), and TE. Chromatin was 
eluted buffer (1% SDS, 0.1 M NaHCO3), and then reverse cross-linked with 0.2 M NaCl 
at 65o C overnight. DNA was purified with a PCR purification kit (QIAGEN) and 
subjected to quantitative PCR or processed for ChIP-sequencing.   
ChIP-PCR oligonucleotides used in this study were as follows (Ji et al., 2010; Hauser et 
al., 2014; Subrahmanyam et al., 2012; Chakraborty et al., 2009; Hesslein, et al, 2003): 
Vha: forward (5’-CCTTCGCCCCAATCCACC-3’), reverse (5’- 
CAAGTAACCCTCAAGAGAATGGAGACTC-3’); Vh47: forward (5’- 
CTACAACCAGAAGTTCAAGGGCAA-3’), reverse 
(TCAGGCTGTGATTACAACACTGTGT-3’); Vh77: forward (5'-
AAATCCTCCAGCACAGCCTA-3'), reverse (5'-TAGACCGCAGAGTCCTCAGA-3'); 
Dsp2: forward (5’- CAACAAAAACCCAGTATGCCCAG-3’), reverse (5’- 
GTGCTTTCACCTGTCTGTGGG-3’); Dfl-4.5: forward (5’- 
AGGCATCTCATCTCACTCTAAGC -3’), reverse (5’- 
TGTGTCCCTCTAAGACGAGTGAAT -3’); Dq52: forward (5’-
CATTGGTCCCTGACTCAAGA-3’), reverse (5’-TCCCAGTTAGCACTGTGGTG-3’);  
Jh1: forward (5’-TGCTACTGGTACTTCGATGTCTG-3’), reverse (5’-
GCCAGCTTACCTGAGGAGAC-3’);  Jh2: forward(5’-CAGTCTCCTCAGGTGAGTCCT), 
reverse (5’-CCCAATGACCCTTTCTGACT-3’);  Jh3: forward (5’-
GCCTGGTTTGCTTACTGG-3’), reverse (5’-GACAAAGGGGTTGAATCT-3’); Jh4: 
forward (5’-CACCAGGAATTGGCATAA-3’), reverse (5’-CCTGAGGAGACGGTGACT-
3’); Sµ: forward (5’-GCTAAACTGAGGTGATTACTCTGAGGT-3’), reverse (5’-
GTTTAGCTTAGCGGCCCAGCTCATTCC-3’); Cµ: forward (5’-
ATGTCTTCCCCCTCGTCTCC-3’), reverse (5’-TACTTGCCCCCTGTCCTCAG-3’);  Sg3: 
(5’-AATCTACAGAGAGCCAGGTGG-3’), reverse (5’-TGGTTTTCCATGTTCCCACTT-
3’);  
Cg: forward (5’-TGGACAAACAGAAGTAGACATGGGTC-3’), reverse (5’-
GGGGTTTAGAGGAGAGAAGGCAC-3’);  
γ-actin: forward (5’-GACACCCAACCCCGTGACG-3’), reverse (5’-
GCGGCCATCACATCCCAG-3’);  
IgHK36me3R1: forward (5’-TGGTTTCGGAGAGGTCCAGA-3’), reverse (5’-
GTAGGCCTGGACTTTGGGTC-3’); IgHK36me3R2: forward (5’-
CAAGCCCAGCTTTGCTTACC-3’), reverse (5’-CTGAGATGGGTGGGCTTCTC-3’);  
IgHK36me3R3: forward (5’-AGGGCTCTCAACCTTGTTCC-3’), reverse (5’-
AGGTCGGCTGGACTAACTCT-3’); IgHK36me3R4: forward (5’-
TCTGGCTTACCATTTGCGGT-3’), reverse (5’-TCGGTGGCTTTGAAGGAACA-3’); 
IgHK36me3R5: forward (5’-TGGCAGAAGCCACAACCATA-3’), reverse (5’-
CCCTCTGGCCCTGCTTATTG-3’);  Hoxa9: forward (5’-
GGAATAGGAGGAAAAAACAGAAGAGG-3’), reverse 
(5’TGTATGAACCGCTCTGGTATCCTT-3’). 
The following variable region ChIP-PCR primers were used for variable region were 
from (Ji et al 2019): V1-1: forward (5’- ACGTCACAGTGAGGATGTGACA-3’), reverse 
(5’- CTAGGCACATATCCTCCAGCAT-3’); V1-7: forward (5’-  
TCATCAAGCCTACAGGTTAGTC-3’), reverse (5’- AGACACAGTGGTGCAACCACAT-
3’); V1-59: forward (5’- CATACTACACACCATCCTGGCT-3’), reverse (5’- 
AACCCTGGAGGAGTAGCAAACT-3’); V6-1: forward (5’- 
CTTCCTACACAAGCCATGGGTA-3’), reverse (5’- GCAACATGTTATGGAGGTTTGT-
3’); D1-1: forward (5’- CTAGACTCAGTTTTTGGAGCTCAA-3’), reverse (5’- 
CTACGGTAGTAGCTACCACAGT-3’); D2-8: forward (5’-
CTGTGGTAGTTACCATAGTAGAC-3’), reverse (5’-CTCTGGCCCCACCAGACAAT-3’); 
D3-1: forward (5’- AAAGCCAGAAAGGGAATAGGTCT-3’), reverse (5’-
CTGTCACAGTGGGCACAGCT-3’); D5-4: (5’-CTGACTGGCTAAACACTGTAGA-3’), 
reverse (5’-CACAAGAGGTGGATTCTGTATGT-3’); J2: forward (5’-
GAGGTTGTAAGGACTCACCTGA-3’), reverse: (5’-
ACATTGTTAGGCTACATGGGTAGA-3’); J3: forward (5’-
CTGCAGAGACAGTGACCAGAGT-3’), reverse (5’-TGGAGCCCTAGCCAAGGATCA-3’) 
 
 
For ChIP-Sequencing libraries were prepared using a ThruPLEX DNA-seq Kit (Rubicon 
Genomics) and validated using a TapeStation (Agilent Technologies) and Qubit 2.0 
Flurometer (Thermo Fisher Scientific). Libraries were pooled and sequenced on a 
HiSeq2000 platform (Illumina). 
 
Quantitative PCR 
RNA isolated from sorted B cell populations and v-Abl cells were subjected to 
quantitative PCR with the following primers and normalized to Gapdh expression: 
From (Chakraborty et al., 2009): Dfl-4.5: forward (5’-
AGGCATCTCATCTCACTCTAAGC-3’), reverse (5’-
TGTGTCCCTCTAAGACGAGTGAAT-3’); Dq52:  forward (5’-
TGGTGCAAGGTTTTGACTAAGC-3’), reverse (CCAAACAGAGGGTTTTTGTTGAG-3’); 
Dsp2: forward (5’-TGTTACCTTACTTGGCAGGGATTT-3’), reverse (5’-
TGGGTTTTTGTTGCTGGATATATC-3’); g-actin: forward (5’-
GGTGTCCGGAGGCACTCTT-3’), reverse (5’-TGAAAGTGGTCTCATGGATACCA-3’);  
Cμ: forward (5’- AGAGATCTGCATGTGCCCATT-3’), reverse (5’-
TGGTGGGACGAACACATTTACA-3’); Eµ (5’): forward (5’-
CTGACATTACTTAAAGTTTAACCGAGG-3’), reverse (5-
CTCCAACTCAACATTGCTCAATTC-3’);  
Eµ(3'): forward (5’-ATTCAGCCGAAACTGGAGAGGTC-3’), reverse (5’-
GGGGAAACTAGAACTACTCAAGC-3’);  
From Zan et al 2017: Aicda: forward (5'-AGAAAGTCACGCTGGAGACC-3'), reverse (5'-
CTCCTCTTCACCACGTAGCA-3'); Rad52: forward (5’-
AGCCAGTATACAGCGGATGAA-3’), reverse (5’-GCCATGCGGCTGCTAATGTA-3’); 
Polq: forward ( 5’- 
TGGCTATATGGGCAGCACCT-3’ 5’-CAGAGCAATGCCCTTGGATTT-3’); Ku70: 
forward  
(5’-CACCAAGCGGTCTCTGACTT-3’), reverse (5’-AGAGAGGGCCTCAGGTAGTG-3’),  
Ku80: forward (5’-AGGCCCAGGAAGCTCTATCA-3’), reverse (5’- 
GCACTCTTGGATTCCCCACA-3’); Gapdh: forward (5′-TTCACCACCATGGAGAAGGC- 
3′), reverse (5′-GGCATGGACTGTGGTCATGA-3′) 
Gapdh: forward (5’-CAAGCAGATGATGTTTCCTGTCC-3’), reverse (5’-
AGAACTAAGGGTGGGTGGTGTAGC-3’) (Wu et al., 2003). 
Lig4: forward (5'-TCTGCCTTTAAGCCAATGCT-3'), reverse (5'-
GTGAGAGAGCCTTCCTGTGG-3'); Xrcc4:  forward (5'-TGTGTGAGTGCCAAAGAAGC-
3'), reverse (5'-TCATCGGTGCTTCCATCATA-3') (Okamura et al., 2016); Lig3: forward 
(5'-CCTCTCCAAGCTCACCAAAG-3'), reverse (5'-TGCTCATTGTGAAGGACTCG-3'); 
Parp1: forward (5'-GCAGCGAGAGTATTCCCAAG-3'), reverse (5'-
CCGTCTTCTTGACCTTCTGC-3') (Meador et al, 2008); Rag1: forward (5’–
TGCAGACATTCTAGCACTCTGG–3’), reverse (5’ ACATCTGCCTTCACGTCGAT–3’); 
Rag2: forward (5’-CACATCCACAAGCAGGAAGTACAC–3’), reverse (5’-
CCCTCGACTATACACCACGTCAA–3’) (Bender et al. 2004);  
Rad51: (5’-CTCATGCGTCAACCACCAG-3’), reverse (5’-
GCTTCAGGAAGACAGGGAGAG-3’) (Pandit et al., 2012). 
 
ATAC-sequencing 
ATAC-seq was performed as previously described (Buenrostro et al., 2013). For each 
sample, cell nuclei were prepared from 5x104 cells and incubated with 2.5 μL 
transposase (Illumina) in a 50 μL reaction for 30 minutes at 37°C. Following purification 
of transposase-fragmented DNA, the library was amplified by PCR and subjected to 
high-throughput sequencing on the HiSeq 2000 platform (Illumina).  
 
NGS Data analysis and statistical methods 
Reads from ChIP-seq and ATAC-seq libraries were trimmed for quality using 
‘trim_galore’ and aligned to mouse genome assembly mm9 with bowtie2 using the 
default parameters and duplicates removed with the Picard tool MarkDuplicates 
(http://broadinstitute.github.io/picard/). Density profiles were created by extending each 
read to the average library fragment size for ChIP and 0 bp for ATAC, then computing 
density using the BEDTools suite (http://bedtools.readthedocs.io). Enriched regions 
were discovered using MACS (v1.4) and scored against matched input libraries (fold 
change > 2 and p-value < 1e-5). Genome browser tracks and read density tables were 
normalized to a sequencing depth of ten million mapped reads.  
 
ChIP and immunoblotting antibodies 
Whole cell extracts for immunoblotting and Chromatin Immunoprecipitations were 
conducted with H3K36me3 (61101 pAb, Active Motif), H3K36me3 (ab9050 Abcam), 
H327me1 (61015 Active Motif), H3K27me2 XP (D18C8, CST), H3K9ac (ab4441, 
Abcam), Hmgb2 (ab67282, Abcam), H3K27me3 (07-449, Millipore), H3K36me 1 
(Ab9048, Abcam), H3K36me2 (ab9049, Abcam), H3K4me3 (Ab8580, Abcam), Rag1 
(NBP1-74190, Novus), total H3 (Ab61251, Abcam), Ku80 (2753, CST), Gapdh (14C10, 
CST), Kmt3a (ab31358, Abcam), Xrcc4 (PA-76068, ThermoFisher), Rag2 (ab133609, 
Abcam), Ku70 (N3H10, ThermoFisher), Lig4 (ab26039, Abcam), phospho-gH2Ax 
(ab11174, Abcam), total H2Ax (7631 ,CST), Vinculin (4650, CST). 
 
Southern Blot analyses 
Southern blot analyses were conducted as described previously (Bredemeyer et al., 
2006; Hung et al., 2018).  Briefly, 10μg of genomic DNA from v-Abl B cells containing 
the pMG-INV recombination substrate were digested with XbaI or NheI and hybridized 
to a P32-labeled probe for Thy1 or GFP.  Thy1 and GFP probes were made from 800bp 
and 700bp cDNA fragments respectively.  After incubating with Thy1 probe, XbaI 
digested Southern blots were stripped and re-probed with the GFP probe. 
 
Detection of Igh CDR3 sequences from NGS of proB genomic DNA 
MiXCR v2.1.11 (Bolotin et al., 2017) was used to detect Igh CDR3 sequences from the 
next generation sequencing data. Only the best matched V/D/J genes were kept for 
each CDR3 sequences. The unproductive CDR3s, which are out of frame or contain 
stop codons, were excluded from the downstream analysis. The number of N-nucleotide 
additions and total deletions were evaluated based on the refPoints column in MiXCR 
output file. Wilcoxon rank sum test was used to compare the difference for the number 
of CDR3 sequences, the length of CDR3 amino acid sequences, the number of N-
nucleotide additions and total deletions between knockout (KO) and WT group. All the 
statistical tests were implemented using R. 
 
RNA-seq data processing for TRUST 
RNA-seq fastq files were aligned to mouse reference genome mm10 using STAR2 
(Dobin et al., 2013). TRUST v3.0.2 (Li et al., 2017; Hu et al., 2018; Hu et al., 2019) was 
used to infer both partial and complete BCR CDR3 sequences and gene coverage from 
the aligned RNA-seq BAM files. For each RNA-seq sample, the B cell percentage was 
estimated by the number of reads mapped to Igh gene region divided by the number of 
total sequencing reads and the BCR diversity was evaluated by the normalized unique 
Igh CDR3 calls (Hu et al., 2019). 
 
Generation, analysis and histology of embryos for neurogenesis 
C57Bl6 Setd2f/f mice were bred to Nestin-cre mice to heterozygosity and timed matings 
between Setd2f/f and Nestin Setd2Δ/+ were established to obtain E14.5, E16.5, E18.5 
embryos and 2 hour post-partum pups.    Tissues were fixed in 10% buffered formalin 
and embedded in paraffin and serially sectioned for sagittal and coronal sections (4 
μm). TUNEL was performed on sections using TUNEL In Situ Cell Death Detection kit, 
POD (Roche) with Terminal Deoxynucleotidyl Transferase buffer (Takara Bio) and 
counterstained with DAPI. Immunostaining of cleaved caspase-3 was performed using 
anti-cleaved caspase-3 (Asp175) (5A1E) (CST 9664) with anti-rabbit conjugated to HRP 
secondary antibodies and visualized with DAB.  Nuclei counterstained with hematoxylin. 
Whole tissues on slides were scanned by a digital slides scanner (3D Histech, MIDI) 
and viewed with Caseviewer (3D Histech). 
 
Statistical analyses  
Error bars in all data shown represent standard deviation. Unless otherwise indicated, 
determination of statistical significance and standard deviations were calculated using 
unpaired two-tailed Student’s t test (when comparing two conditions e.g. control vs 
knockout) or one way ANOVA (when comparing across multiple conditions 
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